It was good. Never visited a Scientific Update conference, but will get it on my priority list. Very good – like the set-up, flow and topics. Very interested in process development.
It was good. Never visited a Scientific Update conference, but will get it on my priority list. Very good – like the set-up, flow and topics. Very interested in process development.
It was good. Never visited a Scientific Update conference, but will get it on my priority list. Very good – like the set-up, flow and topics. Very interested in process development.
The Scientific Update Team had a brilliant evening having dinner and listening to the Jazz on The Pantiles in Royal Tunbridge Wells. To be together celebrating that we are still very much here and have survived the most challenging 18 months in our history, was really rather special. We can’t wait to see you all too at some of our face-to-face events – either during the Autumn or early in 2022.
Peptide drugs have very recently been in the limelight because of the success of the Novo Nordisk blockbuster GLP-1 agonist Semaglutide (Ozempic, Figure 1).1 GLP-1 agonists primarily stimulate glucose- dependent insulin release from pancreatic islets, underpinning its use in the treatment of diabetes. An add-on, equally important, function is the slowing of gastric emptying- reducing…
Bec's Bitesized Blog - Are you in the iPRD Industrial club? Last week, I had the pleasure of attending the Institute of Process Research and Development (iPRD) Industrial Club's autumn meeting in Leeds, a city that holds a special place in my heart, having spent several happy years there during my PhD studies. For those…
Green Magic: How 2024’s Peter J. Dunn Award Winners Transformed Sustainable Pharma with Breakthrough Chemistry Written by Dr Bec Newton, 24 October 2024 I happened to notice a post on LinkedIn about an ACS Webinar last week entitled ‘Sustainable Manufacturing – Green Chemistry Breakthroughs in Pharma’. I’m glad I did as the two talks were…
